
Shares of Theratechnologies (NASDAQ:THTX) rose after the company announced on Thursday that it will be acquired by CB Biotechnology, a subsidiary of Future Pak, in a deal valued at $254M.
CB Biotechnology plans to purchase Theratechnologies for $3.01 per share in